Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Web-Based Intervention and Email-Counseling for Problem Gamblers: Results of a Randomized Controlled Trial.

Jonas B, Leuschner F, Eiling A, Schoelen C, Soellner R, Tossmann P.

J Gambl Stud. 2019 Sep 27. doi: 10.1007/s10899-019-09883-8. [Epub ahead of print]

PMID:
31560101
2.

Functional association of a CD40 gene single nucleotide polymorphism with the pathogenesis of coronary heart disease.

Sultan CS, Weitnauer M, Turinsky M, Kessler T, Brune M, Gleissner CA, Leuschner F, Wagner AH, Hecker M.

Cardiovasc Res. 2019 Aug 2. pii: cvz206. doi: 10.1093/cvr/cvz206. [Epub ahead of print]

PMID:
31373353
3.

15-Deoxy-Δ12,14-Prostaglandin J2 Reinforces the Anti-Inflammatory Capacity of Endothelial Cells With a Genetically Determined NO Deficit.

Urban I, Turinsky M, Gehrmann S, Morgenstern J, Brune M, Milewski MR, Wagner AH, Rumig C, Fleming T, Leuschner F, Gleissner CA, Hecker M.

Circ Res. 2019 Jul 19;125(3):282-294. doi: 10.1161/CIRCRESAHA.118.313820. Epub 2019 Jun 19.

PMID:
31213138
4.

Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunction.

Leuschner F, Nahrendorf M.

Eur Heart J. 2019 Mar 3. pii: ehz159. doi: 10.1093/eurheartj/ehz159. [Epub ahead of print]

PMID:
30945736
5.

Molecular Imaging Visualizes Recruitment of Inflammatory Monocytes and Macrophages to the Injured Heart.

Heo GS, Kopecky B, Sultan D, Ou M, Feng G, Bajpai G, Zhang X, Luehmann H, Detering L, Su Y, Leuschner F, Combadière C, Kreisel D, Gropler RJ, Brody SL, Liu Y, Lavine KJ.

Circ Res. 2019 Mar 15;124(6):881-890. doi: 10.1161/CIRCRESAHA.118.314030.

PMID:
30661445
6.

Delineating the Dynamic Transcriptome Response of mRNA and microRNA during Zebrafish Heart Regeneration.

Klett H, Jürgensen L, Most P, Busch M, Günther F, Dobreva G, Leuschner F, Hassel D, Busch H, Boerries M.

Biomolecules. 2018 Dec 28;9(1). pii: E11. doi: 10.3390/biom9010011.

7.

Transfemoral aortic valve replacement for severe aortic valve regurgitation in a patient with a pulsatile-flow biventricular assist device.

Gomes B, Bekeredjian R, Leuschner F, Ehlermann P, Schmack B, Ruhparwar A, Raake PW, Katus HA, Kreusser MM.

ESC Heart Fail. 2019 Feb;6(1):217-221. doi: 10.1002/ehf2.12384. Epub 2018 Nov 27.

8.

Identification and regulation of the long non-coding RNA Heat2 in heart failure.

Boeckel JN, Perret MF, Glaser SF, Seeger T, Heumüller AW, Chen W, John D, Kokot KE, Katus HA, Haas J, Lackner MK, Kayvanpour E, Grabe N, Dieterich C, von Haehling S, Ebner N, Hünecke S, Leuschner F, Fichtlscherer S, Meder B, Zeiher AM, Dimmeler S, Keller T.

J Mol Cell Cardiol. 2019 Jan;126:13-22. doi: 10.1016/j.yjmcc.2018.11.004. Epub 2018 Nov 13.

PMID:
30445017
9.

Periprocedural antibiotic treatment in transvascular aortic valve replacement.

Gomes B, Geis NA, Leuschner F, Meder B, Konstandin M, Katus HA, Bekeredjian R.

J Interv Cardiol. 2018 Dec;31(6):885-890. doi: 10.1111/joic.12567. Epub 2018 Nov 5.

PMID:
30397939
10.

A CHIP mutation to battle cancer: potential or hazard for cardiovascular disease?

Leuschner F.

Cardiovasc Res. 2018 Nov 1;114(13):e96-e98. doi: 10.1093/cvr/cvy237. No abstract available.

PMID:
30351373
11.

Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis.

Meyer IS, Goetzke CC, Kespohl M, Sauter M, Heuser A, Eckstein V, Vornlocher HP, Anderson DG, Haas J, Meder B, Katus HA, Klingel K, Beling A, Leuschner F.

Front Immunol. 2018 Oct 8;9:2303. doi: 10.3389/fimmu.2018.02303. eCollection 2018.

12.

The role of Wnt signaling in the healing myocardium: a focus on cell specificity.

Meyer IS, Leuschner F.

Basic Res Cardiol. 2018 Oct 16;113(6):44. doi: 10.1007/s00395-018-0705-y. Review.

PMID:
30327885
13.

Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.

Popa M, Tahir S, Elrod J, Kim SH, Leuschner F, Kessler T, Bugert P, Pohl U, Wagner AH, Hecker M.

Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):E5556-E5565. doi: 10.1073/pnas.1801366115. Epub 2018 May 23.

14.

The cardiac microenvironment uses non-canonical WNT signaling to activate monocytes after myocardial infarction.

Meyer IS, Jungmann A, Dieterich C, Zhang M, Lasitschka F, Werkmeister S, Haas J, Müller OJ, Boutros M, Nahrendorf M, Katus HA, Hardt SE, Leuschner F.

EMBO Mol Med. 2017 Sep;9(9):1279-1293. doi: 10.15252/emmm.201707565.

15.

My Transition From a Postdoctoral Fellowship in the United States to Junior Faculty in Europe: Challenges and Opportunities.

Leuschner F.

Circ Res. 2017 Jul 21;121(3):206-207. doi: 10.1161/CIRCRESAHA.117.310654. No abstract available.

PMID:
28729450
16.

Short and long-term results after endovascular management of vascular complications during transfemoral aortic valve implantation.

Heger T, Strauß S, Blessing E, Andrassy M, Erbel C, Müller OJ, Chorianopoulos E, Pleger S, Leuschner F, Korosoglou G, Bekeredjian R, Katus HA, Vogel B.

Acta Cardiol. 2017 Aug;72(4):474-482. doi: 10.1080/00015385.2017.1335455. Epub 2017 Jul 14.

PMID:
28705072
17.

Improvements of Procedural Results With a New-Generation Self-Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old-Generation Device.

Gomes B, Geis NA, Chorianopoulos E, Meder B, Leuschner F, Katus HA, Bekeredjian R.

J Interv Cardiol. 2017 Feb;30(1):72-78. doi: 10.1111/joic.12356. Epub 2016 Nov 24.

PMID:
27882613
18.

Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System.

Jarr KU, Leuschner F, Meder B, Katus HA, Bekeredjian R, Chorianopoulos E.

J Invasive Cardiol. 2017 Jan;29(1):30-35. Epub 2016 Nov 15.

19.

Efficacy of an internet-based intervention for burnout: a randomized controlled trial in the German working population.

Jonas B, Leuschner F, Tossmann P.

Anxiety Stress Coping. 2017 Mar;30(2):133-144. doi: 10.1080/10615806.2016.1233324. Epub 2016 Sep 22.

PMID:
27602992
20.

Therapeutic hypothermia impacts leukocyte kinetics after cardiac arrest.

Dufner MC, Andre F, Stiepak J, Zelniker T, Chorianopoulos E, Preusch M, Katus HA, Leuschner F.

Cardiovasc Diagn Ther. 2016 Jun;6(3):199-207. doi: 10.21037/cdt.2016.02.06.

21.

Macrophages retain hematopoietic stem cells in the spleen via VCAM-1.

Dutta P, Hoyer FF, Grigoryeva LS, Sager HB, Leuschner F, Courties G, Borodovsky A, Novobrantseva T, Ruda VM, Fitzgerald K, Iwamoto Y, Wojtkiewicz G, Sun Y, Da Silva N, Libby P, Anderson DG, Swirski FK, Weissleder R, Nahrendorf M.

J Exp Med. 2015 Apr 6;212(4):497-512. doi: 10.1084/jem.20141642. Epub 2015 Mar 23.

22.

CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury.

Weinreuter M, Kreusser MM, Beckendorf J, Schreiter FC, Leuschner F, Lehmann LH, Hofmann KP, Rostosky JS, Diemert N, Xu C, Volz HC, Jungmann A, Nickel A, Sticht C, Gretz N, Maack C, Schneider MD, Gröne HJ, Müller OJ, Katus HA, Backs J.

EMBO Mol Med. 2014 Oct;6(10):1231-45. doi: 10.15252/emmm.201403848.

23.

Silencing of CCR2 in myocarditis.

Leuschner F, Courties G, Dutta P, Mortensen LJ, Gorbatov R, Sena B, Novobrantseva TI, Borodovsky A, Fitzgerald K, Koteliansky V, Iwamoto Y, Bohlender M, Meyer S, Lasitschka F, Meder B, Katus HA, Lin C, Libby P, Swirski FK, Anderson DG, Weissleder R, Nahrendorf M.

Eur Heart J. 2015 Jun 14;36(23):1478-88. doi: 10.1093/eurheartj/ehu225. Epub 2014 Jun 20.

24.

Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts.

Ueno T, Dutta P, Keliher E, Leuschner F, Majmudar M, Marinelli B, Iwamoto Y, Figueiredo JL, Christen T, Swirski FK, Libby P, Weissleder R, Nahrendorf M.

Circ Cardiovasc Imaging. 2013 Jul;6(4):568-73. doi: 10.1161/CIRCIMAGING.113.000481. Epub 2013 Jun 14.

25.

Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice.

Majmudar MD, Keliher EJ, Heidt T, Leuschner F, Truelove J, Sena BF, Gorbatov R, Iwamoto Y, Dutta P, Wojtkiewicz G, Courties G, Sebas M, Borodovsky A, Fitzgerald K, Nolte MW, Dickneite G, Chen JW, Anderson DG, Swirski FK, Weissleder R, Nahrendorf M.

Circulation. 2013 May 21;127(20):2038-46. doi: 10.1161/CIRCULATIONAHA.112.000116. Epub 2013 Apr 24.

26.

Endoscopic time-lapse imaging of immune cells in infarcted mouse hearts.

Jung K, Kim P, Leuschner F, Gorbatov R, Kim JK, Ueno T, Nahrendorf M, Yun SH.

Circ Res. 2013 Mar 15;112(6):891-9. doi: 10.1161/CIRCRESAHA.111.300484. Epub 2013 Feb 7. Erratum in: Circ Res. 2013 May 24;112(11):e155.

27.

Myocardial infarction accelerates atherosclerosis.

Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, Iwamoto Y, Thompson B, Carlson AL, Heidt T, Majmudar MD, Lasitschka F, Etzrodt M, Waterman P, Waring MT, Chicoine AT, van der Laan AM, Niessen HW, Piek JJ, Rubin BB, Butany J, Stone JR, Katus HA, Murphy SA, Morrow DA, Sabatine MS, Vinegoni C, Moskowitz MA, Pittet MJ, Libby P, Lin CP, Swirski FK, Weissleder R, Nahrendorf M.

Nature. 2012 Jul 19;487(7407):325-9. doi: 10.1038/nature11260.

28.

PET/MRI of inflammation in myocardial infarction.

Lee WW, Marinelli B, van der Laan AM, Sena BF, Gorbatov R, Leuschner F, Dutta P, Iwamoto Y, Ueno T, Begieneman MP, Niessen HW, Piek JJ, Vinegoni C, Pittet MJ, Swirski FK, Tawakol A, Di Carli M, Weissleder R, Nahrendorf M.

J Am Coll Cardiol. 2012 Jan 10;59(2):153-63. doi: 10.1016/j.jacc.2011.08.066.

29.

Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis.

Leuschner F, Rauch PJ, Ueno T, Gorbatov R, Marinelli B, Lee WW, Dutta P, Wei Y, Robbins C, Iwamoto Y, Sena B, Chudnovskiy A, Panizzi P, Keliher E, Higgins JM, Libby P, Moskowitz MA, Pittet MJ, Swirski FK, Weissleder R, Nahrendorf M.

J Exp Med. 2012 Jan 16;209(1):123-37. doi: 10.1084/jem.20111009. Epub 2012 Jan 2.

30.

Therapeutic siRNA silencing in inflammatory monocytes in mice.

Leuschner F, Dutta P, Gorbatov R, Novobrantseva TI, Donahoe JS, Courties G, Lee KM, Kim JI, Markmann JF, Marinelli B, Panizzi P, Lee WW, Iwamoto Y, Milstein S, Epstein-Barash H, Cantley W, Wong J, Cortez-Retamozo V, Newton A, Love K, Libby P, Pittet MJ, Swirski FK, Koteliansky V, Langer R, Weissleder R, Anderson DG, Nahrendorf M.

Nat Biotechnol. 2011 Oct 9;29(11):1005-10. doi: 10.1038/nbt.1989.

31.

In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation.

Panizzi P, Nahrendorf M, Figueiredo JL, Panizzi J, Marinelli B, Iwamoto Y, Keliher E, Maddur AA, Waterman P, Kroh HK, Leuschner F, Aikawa E, Swirski FK, Pittet MJ, Hackeng TM, Fuentes-Prior P, Schneewind O, Bock PE, Weissleder R.

Nat Med. 2011 Aug 21;17(9):1142-6. doi: 10.1038/nm.2423.

32.

Mucosal tolerance induction in autoimmune myocarditis and myocardial infarction.

Li J, Göser S, Leuschner F, Volz HC, Buss S, Andrassy M, Öttl R, Pfitzer G, Katus HA, Kaya Z.

Int J Cardiol. 2013 Jan 20;162(3):245-52. doi: 10.1016/j.ijcard.2011.05.057. Epub 2011 Jun 17.

PMID:
21684025
33.

Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic.

Leuschner F, Nahrendorf M.

Circ Res. 2011 Mar 4;108(5):593-606. doi: 10.1161/CIRCRESAHA.110.232678. Review.

34.

Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomography-computed tomography.

Nahrendorf M, Keliher E, Marinelli B, Leuschner F, Robbins CS, Gerszten RE, Pittet MJ, Swirski FK, Weissleder R.

Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):750-7. doi: 10.1161/ATVBAHA.110.221499. Epub 2011 Jan 20.

35.

Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction.

Leuschner F, Panizzi P, Chico-Calero I, Lee WW, Ueno T, Cortez-Retamozo V, Waterman P, Gorbatov R, Marinelli B, Iwamoto Y, Chudnovskiy A, Figueiredo JL, Sosnovik DE, Pittet MJ, Swirski FK, Weissleder R, Nahrendorf M.

Circ Res. 2010 Nov 26;107(11):1364-73. doi: 10.1161/CIRCRESAHA.110.227454. Epub 2010 Oct 7.

36.

Autoimmune myocarditis: past, present and future.

Leuschner F, Katus HA, Kaya Z.

J Autoimmun. 2009 Nov-Dec;33(3-4):282-9. doi: 10.1016/j.jaut.2009.07.009. Epub 2009 Aug 12. Review.

PMID:
19679447
37.

4-Methyl-2H-1,3-oxazine-2,6(3H)-dione.

Parrish D, Leuschner F, Rehberg GM, Kastner ME.

Acta Crystallogr Sect E Struct Rep Online. 2009 Sep 5;65(Pt 10):o2354. doi: 10.1107/S1600536809034618.

38.

Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis.

Kaya Z, Göser S, Buss SJ, Leuschner F, Ottl R, Li J, Völkers M, Zittrich S, Pfitzer G, Rose NR, Katus HA.

Circulation. 2008 Nov 11;118(20):2063-72. doi: 10.1161/CIRCULATIONAHA.108.788711. Epub 2008 Oct 27.

39.

Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction.

Leuschner F, Li J, Göser S, Reinhardt L, Ottl R, Bride P, Zehelein J, Pfitzer G, Remppis A, Giannitsis E, Katus HA, Kaya Z.

Eur Heart J. 2008 Aug;29(16):1949-55. doi: 10.1093/eurheartj/ehn268. Epub 2008 Jun 13.

PMID:
18556712
40.

An optical threshold function based on polarization rotation in a single semiconductor optical amplifier.

Geldenhuys R, Liu Y, Vegas Olmos JJ, Leuschner FW, Khoe GD, Dorren HJ.

Opt Express. 2007 Jun 11;15(12):7275-80.

PMID:
19547050
41.

Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium.

Göser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, Zittrich S, Blaudeck N, Hardt SE, Pfitzer G, Rose NR, Katus HA, Kaya Z.

Circulation. 2006 Oct 17;114(16):1693-702. Epub 2006 Oct 2.

PMID:
17015788
42.

Complement receptors regulate lipopolysaccharide-induced T-cell stimulation.

Kaya Z, Tretter T, Schlichting J, Leuschner F, Afanasyeva M, Katus HA, Rose NR.

Immunology. 2005 Apr;114(4):493-8.

43.

Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis.

Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F, Rose NR.

J Immunol. 2002 Feb 15;168(4):1552-6.

44.

[Physical chemical, pharmacological and toxicologic properties of fomocaine metabolites] .

Seeling A, Leuschner F, Oelschläger H.

Arzneimittelforschung. 2001 Jan;51(1):7-17. German.

PMID:
11215329
45.

[The potential nephrotoxic effects of essential juniper oil].

Schilcher H, Leuschner F.

Arzneimittelforschung. 1997 Jul;47(7):855-8. German.

PMID:
9324932
46.

[The adverse effects of dark sulfonated shale oil following local and systemic administration].

Cholcha W, Leuschner J, Leuschner F.

Arzneimittelforschung. 1994 Jul;44(7):844-9. German.

PMID:
7945520
47.

[The tolerability of pale sulfonated shale oil following local and systemic administration].

Cholcha W, Leuschner J, Leuschner F.

Arzneimittelforschung. 1994 Feb;44(2):170-7. German.

PMID:
7908523
48.

[Pharmacokinetic aspects of a combination of metoclopramide and paracetamol. Results of a human kinetic study and consequences for migraine patients].

Becker A, Berner G, Leuschner F, Vögtle-Junkert U.

Arzneimittelforschung. 1992 Apr;42(4):552-5. German.

PMID:
1642681
49.

Evaluation of the mutagenicity of chloral hydrate in vitro and in vivo.

Leuschner J, Leuschner F.

Arzneimittelforschung. 1991 Oct;41(10):1101-3.

PMID:
1799393
50.

Toxicokinetic aspects of chronic cyanide exposure in the rat.

Leuschner J, Winkler A, Leuschner F.

Toxicol Lett. 1991 Jul;57(2):195-201.

PMID:
1853364

Supplemental Content

Loading ...
Support Center